“NMR Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells” (2018) Radiology and Oncology, 52(4). Available at: https://www.radioloncol.com/index.php/ro/article/view/2963 (Accessed: 23 September 2026).